
Connect practitioners with clinical and cost information
Healthcare is under intense pressure. Staffing crises and shrinking budgets make traditional care models harder to deliver. Meanwhile, an aging population with more chronic conditions needs high-touch care more than ever.
To keep up, the care team is evolving. Innovative care models and platforms increase the need for easy access to accurate patient information and better intelligence sharing between care providers. That’s why we’re bringing more clinical and cost information to practitioners throughout healthcare so patients get exceptional care, wherever they turn.
23,000
pharmacies using Clinical Direct Messaging to quickly collaborate across healthcare1
7–10
daily phone calls eliminated by one pharmacy group with Real-Time Prescription Benefit2
Key products to support care team evolution
Clinical Direct Messaging
Let pharmacists, prescribers and other healthcare professionals reliably send and receive information across multiple care collaboration scenarios within their existing workflows.
Eligibility
Enable easy access to prescription benefit coverage information in prescribing and pharmacy workflows to increase adherence and boost patient satisfaction.
Real-Time Prescription Benefit
Help clinicians solve for affordability and adherence at multiple points in the care journey with patient-specific costs, benefit information and therapeutic alternatives.
The Surescripts Platform
Powering the future of healthcare
Health intelligence sharing at scale requires powerful infrastructure. The Surescripts Platform supports every Surescripts product and every Network Alliance participant with industry-leading reliability, security and scalability.
Real-world results
Keep pace with healthcare innovation
- Surescripts, “2022 National Progress Report,” March 2023.
- Surescripts, “2022 Medication Affordability & Adherence Impact Report,” September 2022.
- CAQH, 2020 CAQH Index: Closing the Gap: The Industry Continues to Improve, But Opportunities for Automation Remain, 2021, p. 6.